Physician profile
Eric Simpson
NPI 1508365016
$5,583.82
in general payments reported to CMS, 2019-2025
8 companies · $3,883 in 2025
The $3,883 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $519 · 2023: $180 · 2024: $873 · 2025: $3,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,584 · Travel and Lodging: $2,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.64 |
| Travel and Lodging | $2,352.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,427.51 | 2021-2025 | 2nd Gen Centrimag Primary Console, Epic, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,283.91 | 2024-2025 | Impella |
| Medtronic, INC. | $394.85 | 2024-2025 | Mc3 Nautilus(Tm) Ecmo Oxygenator |
| Axsome Therapeutics, INC. | $135.36 | 2025 | Auvelity |
| La Jolla Pharmaceutical Company | $126.28 | 2022 | |
| Haemonetics Corporation | $103.63 | 2024 | Teg6s Hemostasis System |
| Procyrion, INC. | $81.27 | 2024 | |
| Becton, Dickinson and Company | $31.01 | 2025 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.